Insider Transactions in Q4 2025 at Genelux Corp (GNLX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2025
|
Ralph Smalling Head of Regulatory |
SELL
Open market or private sale
|
Direct |
165
-0.24%
|
$660
$4.69 P/Share
|
|
Dec 01
2025
|
John Thomas Director |
SELL
Open market or private sale
|
Direct |
10,000
-1.99%
|
$50,000
$5.0 P/Share
|
|
Nov 17
2025
|
Joseph Cappello Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
973
-0.62%
|
$4,865
$5.37 P/Share
|
|
Nov 17
2025
|
Thomas Zindrick President and CEO |
SELL
Open market or private sale
|
Direct |
4,509
-0.83%
|
$22,545
$5.37 P/Share
|
|
Nov 17
2025
|
Tony Yu SVP, Clinical Development |
SELL
Open market or private sale
|
Direct |
973
-0.66%
|
$4,865
$5.37 P/Share
|
|
Nov 17
2025
|
Ralph Smalling Head of Regulatory |
SELL
Open market or private sale
|
Direct |
343
-0.5%
|
$1,715
$5.37 P/Share
|